Your browser doesn't support javascript.
loading
Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.
Wang, Hai-Bo; Zhu, Shuang-Li; Zheng, Jing-Shan; Gou, Ai-Li; Cui, Hui; Zhang, Yong; Ning, Gui-Jun; Fan, Chun-Xiang; Chen, Yuan-Sheng; Li, Ke-Li; Yuan, Ping; Ma, Chao; Ma, Jing; Zheng, Hui; Fan, Xin-Chun; Li, Xin-Lan; Tang, Hai-Shu; Li, Xiao-Lei; Zhang, Fan; Yan, Dong-Mei; Wang, Dong-Yan; Cui, Zhi-Qiang; Ren, Li-Ping; Zhu, Hui; Wang, Hui-Ling; Jiang, Xiao-Hong; An, Hong-Qiu; Liu, Yang; Li, Jing; Xu, Wen-Bo; Wen, Ning; Xu, Ai-Qiang; Luo, Hui-Ming.
Afiliação
  • Wang HB; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhu SL; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zheng JS; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Gou AL; Expanded Program on Immunization, Xinjiang Uygur autonomous region Center for Disease Control and Prevention, Urumqi city, Xinjiang Uygur autonomous region, China.
  • Cui H; Expanded Program on Immunization, Xinjiang Uygur autonomous region Center for Disease Control and Prevention, Urumqi city, Xinjiang Uygur autonomous region, China.
  • Zhang Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ning GJ; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Fan CX; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Chen YS; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Li KL; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yuan P; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ma C; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ma J; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zheng H; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Fan XC; Expanded Program on Immunization, Xinjiang Uygur autonomous region Center for Disease Control and Prevention, Urumqi city, Xinjiang Uygur autonomous region, China.
  • Li XL; Expanded Program on Immunization, Xinjiang Uygur autonomous region Center for Disease Control and Prevention, Urumqi city, Xinjiang Uygur autonomous region, China.
  • Tang HS; Expanded Program on Immunization, Xinjiang Uygur autonomous region Center for Disease Control and Prevention, Urumqi city, Xinjiang Uygur autonomous region, China.
  • Li XL; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhang F; Hunan Provincial Center for Disease Control and Prevention, Changsha, China.
  • Yan DM; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang DY; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Cui ZQ; Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.
  • Ren LP; Liaoning Provincial Center for Disease Control and Prevention, Shenyang, China.
  • Zhu H; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang HL; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Jiang XH; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • An HQ; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Liu Y; Tianjin Center for Disease Control and Prevention, Tianjin, China.
  • Li J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu WB; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wen N; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu AQ; Shandong University Institute for Prevention Medicine, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong Center for Disease Control and Prevention, Jinan city, Shandong Province, China.
  • Luo HM; Expanded Program on Immunization, Chinese Center for Disease Control and Prevention, Beijing, China.
PLoS One ; 9(7): e80069, 2014.
Article em En | MEDLINE | ID: mdl-24991811
ABSTRACT

BACKGROUND:

After being polio free for more than 10 years, an outbreak following importation of wild poliovirus (WPV) was confirmed in Xinjiang Uygur Autonomous Region, China, in 2011.

METHODS:

A cross-sectional study was conducted prior to supplementary immunization activities (SIAs), immediately after the confirmation of the WPV outbreak. In selected prefectures, participants aged ≤ 60 years old who visited hospitals at county-level or above to have their blood drawn for reasons not related to the study, were invited to participate in our study. Antibody titers ≥ 8 were considered positive.

RESULTS:

Among the 2,611 participants enrolled, 2,253 (86.3%), 2,283 (87.4%), and 1,989 (76.2%) were seropositive to P1, P2 and P3 respectively, and 1744 (66.8%) participants were seropositive to all the three serotypes. Lower antibody seropositivities and geometric mean titers were observed in children <1 year of age and in adults aged 15-39 years.

CONCLUSION:

Serosurveys to estimate population immunity in districts at high risk of polio importation might be useful to gauge underlying population immunity gaps to polio and possibly to guide preparedness and response planning. Consideration should be given to older children and adults during polio risk assessment planning and outbreak response.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poliomielite / Surtos de Doenças / Poliovirus / Anticorpos Antivirais Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País como assunto: Asia Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poliomielite / Surtos de Doenças / Poliovirus / Anticorpos Antivirais Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País como assunto: Asia Idioma: En Ano de publicação: 2014 Tipo de documento: Article